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Abstract: Fibronectins are considered to be
molecules that play important roles in cell
migration and cell differentiation. Fibronectin
molecules are thought to influence the
differentiation of trophoblasts and the
adhesion of these cells to maternal tissues.
The aim of the present study was to analyze
the distribution of fibronectin isoforms and to
evaluate the differences between matrix-type
fibrinoids, and other types of matrices
produced by both maternal and fetal tissues.

Department of Biochemistry, Faculty of
Medicine, Akdeniz University, Antalya - Turkey

Tissue samples were collected from different
sites of human term placentas. By using
immunohistochemistry, the expression of
fibronectin isoforms was determined and they
were demonstrated by SDS-PAGE and
Western blotting methods.

Introduction
Fibronectins are adhesive mosaic glycoproteins
comprised of three general types of homologous iterative
modules. These modular units are used as basic building
blocks to form domains that develop distinct functions
such as the establishment and maintenance of normal cell
morphology, cell migration, homeostasis and thrombosis,
wound healing, and oncogenic transformation (1).
Although fibronectin is encoded by only one gene, this
protein exists in a number of variant isoforms due to
alternative
splicing
and/or
post-translational
modifications. These comprise modifications such as
glycosylations and splicing at three general regions of the
precursor mRNA: IIICS, ED-A and ED-B (2). Plasma
fibronectin isoforms lack the alternatively spliced
domains, whereas cellular fibronectin isoforms contain
the ED-A domain in their protein (3).

*

In nearly all tissues reactivities to fibronectin
isoforms were determined. The strongest
reactivities for cellular and oncofetal
fibronectins were found in areas like the basal
plate, chorionic plate and chorion laeve, which
are occupied by invasive trophoblast cells in
high numbers. These results can lead to the
conclusion that extravillous trophoblast (EVT)
cells emerge from the same differentiation
route in different sites of the placenta.
Amnion having no EVT cells consisted of all
fibronectin isoforms. The presence of
oncofetal isoforms especially indicates the
high healing activity of this tissue due to the
rapidly growing fetus and its membranes.

Key Words: fibronectin, human placenta,
extracellular matrix, pregnancy

In transformed cells and malignancies the alternative
splicing of the primary transcript of fibronectin is
deregulated (4). The fibronectin isoforms containing the
domains III-A (ED-A), III-B (ED-B) and III-V (IIICS) are
expressed to a higher degree in transformed human cells
and in tumor tissues than in their normal counterparts
(5,6). Fibronectin containing the III-B sequence are
detectable almost exclusively in healing wounds, in fetal
tissues and in tumor tissues (7,8).
In the human placenta, the fibronectin molecule is
detectable in various sites such as the amnion, basal plate,
chorionic plate, decidua, placental fibrinoid, umbilical cord
and villi. Although the presence of all fibronectin isoforms
is not studied in the extracellular matrices (ECMs) of all
these sites, in particular, the special matrix of invasive
extravillous trophoblast (EVT) cells, a matrix-type
fibrinoid, is evaluated in detail. Huppertz et al. (9)

This paper was partly adapted from Dr. Demir-Weusten’s PhD thesis entitled „Extrazellulare Matrices in der reifen menschlichen Placenta:
Verteilung von Fibronektin-Izoformen und Matrixmetalloproteinasen“ that has been submitted at RWTH, Aachen, Germany.
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showed that the patches of fine fibrillar networks of
matrix-type fibrinoids were immunocytochemically
reactive with the general (IST-4, IST-6), cellular (IST-9)
and oncofetal isoforms (BC-1, FDC-6) of fibronectin.
These molecules, especially oncofetal isoforms, are used
in the differentiation of trophoblast cells from a
proliferative subtype to an invasive subtype.
The aim of this study was to present the differences
between matrix-type fibrinoids and the other matrices of
fetal or maternal origin. For this purpose, different ECMs
were extracted from various regions of human term
placentas. Following extractions, the distribution of
fibronectin isoforms within these ECMs was evaluated
and compared using immunohistochemical and
biochemical techniques.

Materials and Methods
Immunohistochemistry
Tissue samples from 7 term human placentas were
used. Placental tissue in the form of cubes with a maximal
3
edge length of 20 x 20 x 5 mm were fixed in phosphatebuffered neutral 4% formaldehyde solution for a
maximum of 24 h at 4 °C. The specimens were
dehydrated in a graded series of ethanol and embedded in
paraffin (melting point 52 °C; Merck, Darmstadt,
Germany) using xylene as an intermedium, while not
exceeding a temperature of 58 °C. Serial sections (3-5
µm) were cut and mounted on glass slides. The sections
were then deparaffinized using xylene and a graded series
of ethanol (10 min each step).
Immunohistochemical staining was performed
according to a standardized sequence as described before
(10). In brief, endogenous peroxidases and nonspecific
binding were blocked with 3% hydrogen peroxide in
methanol and with swine serum (1:20) in 0.05 M TrisHCl, pH 7.6, 15 mM sodium azide, 6% BSA, respectively.
After incubating with primary antibodies (see for details,
11) in 0.05 M Tris-HCl, pH 7.6, 15 mM sodium azide,
12.5% BSA, a biotinylated link antibody (Dako, E453,
swine antibody, 1:25) was applied for 30 min.
Subsequently, the binding of streptavidin-horseraddishperoxidase (Dako, P397, 1:400) to the antibody-antigen
complexes was detected with an AEC chromogen. Tissue
sections were examined and photomicrographs were
taken with a Zeiss microscope.
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Biochemistry

Tissue preparation
Human term placentas (n = 7) were collected from
clinically normal pregnancies terminated by either vaginal
deliveries or cesarean sections. After their immediate
transfer on ice, samples (5-10 g) from different regions
(amnion, basal plate, chorionic plate, decidua, chorion
laeve, Nitabuch’s fibrinoid, umbilical cord and villi) were
cut out as precisely as possible, put into 5% sucrose in
PBS, pH 7.4, frozen in liquid nitrogen, and stored at –35
°C until further use.

Extraction procedure and protein determination
The extraction of matrix proteins was performed on
ice in the presence of protease inhibitors (Protease
inhibitor cocktail, Boehringer) as can be seen in the PhD
thesis (see for details, 11).
Before electrophoresis the protein concentration of
each aliquot was determined using an Elisa reader (using
Microwin or Easywin software program), at either 620
nm with Bradford (Biorad, Munich) or 700 nm with DCLowry (Biorad) protein estimation assay.

SDS-polyacrylamide gel electrophoresis and
Western blotting
SDS-polyacrylamide gel electrophoresis was carried
out under reducing conditions. The 7% separating gel
was overlayered with a stacking gel containing 3%
polyacrylamide. Samples with the same protein
concentration (15-20 µg/per lane), were incubated for 30
min at room temperature in sample buffer made up of
62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% sucrose,
0.005% bromphenol blue and 5% 2-mercaptoethanol.
Before loading the samples, they were centrifuged for 10
min at 13,500 rpm (Hermle, 220.59 V07). The proteins
were separated at 25mA/plate in 25 mM Tris-HCl, pH
6.8, 192 mM Glycine, 0.1% SDS for approximately 1.5 h
until the dye front reached the end of the gel. After
electrophoresis the gels were either stained with
Coomassie blue R-250 or subjected to semi-dry transfer
on PVDF membranes (Westran, 0.2 µm, Schleicher &
Schuell, Germany) at 200 mA for 20 min. Following the
transfer of proteins, the blotted membranes were
blocked with 5% nonfat dry milk in 0.05% Tween
20/PBS, pH 7.4 for 2 h and incubated with the primary
antibodies (see for details, 11) overnight and developed
using gold-labeled goat anti-mouse IgG or IgM for 2 h
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and a silver enhancement kit for 40 min (Amersham Life
Sciences). The immunoreactivities were evaluated by gel
print 2000I (Biophotonics Corporation, MWG-Biotech)
and scananalytics (Billerica) (see for details, 11).

Results
Immunohistochemistry
Fibronectins in general (IST-4, IST-6, 3E1)

IST-4 (III-5 domain of all fibronectin isoforms)
Amniotic basal lamina was very faintly
immunoreactive with this antibody, whereas the amniotic
epithelium and mesoderm showed no immunoreactivity.
The chorionic mesoderm was also faintly
immunoreactive. The EVT cells in the chorionic plate,
appearing like cell islands between the villi and cell
columns and in the basal plate, showed quite remarkable,
patchy like distribution in their matrices (Figs. 1A-C). In
the cell columns immunoreactivity increased from the
proximal to distal parts. ECMs of decidual cells in the
basal plate were also immunoreactive. The stroma of
large stem villi showed immunopositivity, whilst
trophoblastic cover remained immunonegative. The walls
of large arteries in these stem villi also showed no
immunoreactivity. Other types of villi of a smaller caliber
did not show immunopositivity in the stroma or in the
trophoblastic cover (not shown in data).

IST-6 (III-7/8 domain of fibronectin lacking III-B
domain)
The amnion, amniotic epithelium, basal lamina and
mesoderm were not immunoreactive to this antibody.
The chorionic mesoderm was very faintly
immunoreactive. The EVT cells in the chorionic plate,
appearing like cell islands between the villi and in the cell
columns of the basal plate, showed similar appearances as
obtained by IST-4 (Figs. 2A-C). The matrices of decidual
cells in the basal plate were also immunoreactive (Fig.
2D). In stem villi, the stroma was immunopositive, the
walls of the big arteries gave a very faint reaction and the
trophoblastic cover was immunonegative. Other types of
villi did not show immunopositivity in the stroma or in the
trophoblastic cover.

3E1 (heparin binding domain of all fibronectin
isoforms)
Amniotic epithelium showed no immunoreactivities,
but basal lamina underlying the epithelium and amniotic
mesoderm was immunoreactive to this antibody. The

chorionic mesoderm was faintly immunoreactive and EVT
cells in the chorionic plate were rarely immunopositive.
The stroma of stem villi and anchoring villi were
immunoreactive, whereas the stroma of the other types
of villi were faintly immunoreactive. The walls of the
large arteries were immunopositive. In the basal plate
there were spot-like irregular immunoreactivities. The
trophoblast cells in cell islands were not immunoreactive.
In the basal plate decidua cells were almost
immunonegative.
Cellular fibronectins

3E3 (cell binding domain of cellular fibronectins)
This antibody was immunoreactive with amniotic
basal lamina and mesoderm, but was not reactive with
amniotic epithelium. The chronic mesoderm was
immunopositive, but trophoblast cells did not show
reactivity. The stroma of villi was immunoreactive, whilst
the trophoblastic cover of villi did not show this
appearance. The basal plate stroma of anchoring villi and
trophoblast cells were very weakly reactive. Decidual
ECMs were also very weakly positive.

IST-9 (III-A domain of cellular fibronectins)
IST-9 showed reactivities very similar to those of IST4 and IST-6. The amnion in all its parts showed no
immunoreactivity, whereas the border line of the
chorionic mesoderm was very weakly reactive and the
patchy distribution of the reactivity in the ECMs of EVT
cells was remarkable. The stroma of stem villi were very
weakly immunoreactive, but their trophoblastic cover
was not reactive. Other types of villi did not show
immunopositivity in the stroma or in the trophoblastic
cover, but the appearance of cell islands between the villi
were immunoreactive. Cell columns in the basal plate
containing EVT cells also showed a patchy distribution in
their ECMs. The ECMs of decidual cells and EVT cells in
the basal plate were also immunoreactive.
Oncofetal fibronectins

FDC-6 (O-glycosylated III-V domain)
FDC-6 was reactive with amniotic basal lamina,
whereas it was not reactive with amniotic mesoderm or
amniotic epithelium (Fig. 3A). Chorionic mesoderm
showed very faint reactivity, while the EVT cells of the
chorionic plate had the typical appearance of the
patchwork distribution in their ECMs (Fig. 3B). The
stroma of the stem villi and of the other types of villi and
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Figure 1.
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Micrographs showing immunoreactivities with IST-4 in the extracellular matrices of extravillous trophoblast (with EVT) cells in chorionic
plate (with CP) (A), in cell islands (with CI) (B) and in basal plate (with BP) (C). Original magnification x25.
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Figure 2.

Immunoreactivities with IST-6 in chorionic plate (with CP) (A), in cell islands (with CI) (B), in cell columns (with CC) (C) and in the decidual
part of the basal plate (with BP) (D) are seen. A strong immunoreactivity of EVT cells with extracellular matrices in different placental sites
is definitely indicated. AV: anchoring villi. Original magnification x25.
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Figure 3.

Immunoreactivities with FDC-6 in separated amniotic membrane (with AM) (A), chorionic plate (with CP) (B) and in basal plate (with BP) (C). Amniotic membrane (with AM) and its
some components are immunonegative except the basal lamina of amniotic epithelium that is weakly immunopositive, whereas CP with EVT cells and their extracellular matrices and
BP give off strong positive immunodetection for the FDC-6 antibody. The chorionic mesenchyme is immunonegative. Original magnification x25.
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their trophoblastic cover showed no immunoreactivities.
In the cell islands between the chorionic villi tree, EVT
cells in the basal plate and also the decidual cells showed
reactivities in their ECMs (Fig. 3C).
Biochemistry
Fibronectins in extracellular matrices of human term
placenta were solubilized by the application of extraction
buffer (for details, 11) and the supernatants that were
obtained in this last step were applied on SDS-PAGE (Fig.
4) followed by the quantification of fibronectin isoforms
on Western blots. The signal of each fibronectin isoform
was analyzed and compared by the integration of
detected optical densities (for details, 11).
Fibronectins in general

IST-4 (III-5 domain of all fibronectin isoforms)
The immunoreactivities of this antibody gave the
strongest signal with the chorion laeve extract, which was
then followed by the preparations from the amnion and
chorionic plate. Extracts from the basal plate, villi,
umbilical cord and decidua were reactive with IST-4 less
intensely, but had densities very similar to each other.
The weakest signal was detected in the preparations of
Nitabuch’s fibrinoid (Figs. 5A-F and 6A-G).

IST-6 (III-7/8 domain of fibronectin lacking III-B
domain)
The most intense immunoreactivities to this antibody
were detected in the amnion and chorion laeve
preparations. The density of chorionic plate extract was
very close to the densities detected in the amnion and
chorion laeve extracts. The basal plate extract preparation
had an intenser immunoreactivity than the preparations
from the decidua, umbilical cord and Nitabuch’s fibrinoid.
While these last three extracts had very similar
reactivities, the villi preparation showed the weakest
immunoreactivity (Figs. 5A-F and 6A-G).

3E1 (heparin binding domain of all fibronectin
isoform)
The immunoreactions of this antibody showed similar
intensities with different extracts. Among them, chorion
laeve and amnion extracts were the leading dense signals.
Chorionic plate and Nitabuch’s fibrinoid extracts had the
same level of detected density. The umbilical cord
followed the last two with very close intensity. The rest
of the sequel was formed by the preparations from the
basal plate, decidua and villi (Figs. 5A-F and 6A-G).

In addition, another immunoreactive band around the
41-43kD region was detected.

4B2 (gelatin binding domain of all fibronectin
isoforms)
This antibody was intensely immunoreactive with the
preparation from the chorion laeve, which was then
followed by the amnion, chorionic plate, villi, umbilical
cord, basal plate and Nitabuch’s fibrinoid (Figs. 5A-F and
6A-G).
Cellular fibronectins

3E3 (cell binding domain of cellular fibronectins)
This antibody, similar to the other fibronectin
antibodies, was strongly immunoreactive with the extract
from the chorion laeve, which was followed by amnion
and chorionic plate extracts. Intensity signals from the
preparations of the decidua and Nitabuch’s fibrinoid were
close to each other and were denser than the basal plate
and villi (Figs. 5A-F and 6A-G).

IST-9 (III-A domain of cellular fibronectins)
IST-9 showed the strongest immunoreactivity to the
chorion laeve extract of, which was followed by signals
from chorionic plate and Nitabuch’s fibrinoid
preparations. The densities of the last two extracts were
close to each other and were higher than the signals of
amnion and umbilical cord, which were also at the same
intensity level. The densities detected from villi, decidua
and basal plate extracts completed the sequel with their
lower intensities (Figs. 5 A-F and 6A-G).
Oncofetal fibronectins

FDC-6 (O-glycosylated III-V domain)
FDC-6 was significantly immunoreactive with the
chorion laeve extract. Amnion and chorionic plate
preparations had close intensities and followed the signal
of the chorion laeve. The decidua, Nitabuch’s fibrinoid,
basal plate, villi and umbilical cord extracts followed the
first three signals from high to low intensities (Figs. 5AF and 6A-G).

Discussion
Immunohistochemistry and biochemistry results have
revealed that the amniotic basal lamina is mainly formed
by fibronectins having III-5, heparin binding, cell binding
and O-glycosylated III-V domains. The amniotic
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Figure 4.

A representative SDS-PAGE with the extracts from different sites in the human term placenta. This application design is also used for
Western blots. From left to right: molecular weight markers, extractions from amnion (a), basal plate (b), chorionic plate (c), decidua (d),
chorion laeve (e), Nitabuch’s fibrinoid (f), umbilical cord (g) and chorionic villi (h). The signal of each fibronectin isoform is detectable for
analysis and cooperation by the integration of detected optical densities are seen.

mesoderm is formed by fibronectins having heparin and
cellular binding domains. Western blots demonstrated
that amnion is also composed of fibronectins having III7/8 and III-A domains. In previous studies, the presence
of fibronectin in amnion was reported (12), while human
amnion epithelial cells were shown to secrete cellular (IIIA domain containing) and oncofetal (III-B containing)
fibronectin isoforms that are assembled in the ECMs
(13,14). The expression of oncofetal fibronectin in the
amniotic basal lamina can be a part of the healing process
due to the rapidly growing fetus and its membranes
partly causing shears in the amnion.
In the basal and chorionic plates there are three
isoforms of fibronectin (familiar, cellular and oncofetal)
present both in imminohistochemistry and in Western
blots. Especially in distal parts of the cell columns and in
the trophoblastic layer of the chorionic mesenchyme,
these isoforms were distributed in a spot-like manner
between the EVT cells in agreement with previous reports
(9,15).
On
the
other
hand,
although
452

immunohistochemistry results were not available from
the chorion laeve, the trophoblastic layer of the chorionic
plate can also be representative of this placental site. In
Western blots chorion laeve extracts gave the highest
signals with general, cellular and oncofetal fibronectins.
This might be due to the concentrated presence of EVT
cells and their matrices in this region. The presence of
oncofetal fibronectins in the regions where EVT cells are
in great numbers especially suggest the importance of the
chorion-decidual interface together with the other
fibronectin isoforms (16). This would probably influence
the differentiation of proliferative trophoblast cells into
an invasive type. It would also enhance trophoblast
adhesion to maternal tissues and facilitate trophoblast
migration.
Decidual tissue was taken from the basal plate for
immunohistochemistry, while decidual tissue for Western
blots was derived from fetal membranes. In both
techniques the results were parallel to each other
revealing the presence of fibronectin isoforms (general,

A. Y. DEM‹R-WEUSTEN

Figure 5.

Representative Western blots from the extractions of different placental sites with antibodies against different fibronectin isoforms. The
order of blots is similar to that in Figure 4. The immunoreactivity of different levels is seen with IST-4 (A), IST-6 (B), 3E1 (C), 4B2 (Ç), 3E3
(D), IST-9 (E), and with FDC-6 (F).

cellular and oncofetal) in decidual tissue. In a previous
study, the presence of fibronectin in the pericellular
basement membrane (17), in the pericellular matrix (18)
and in cell cytoplasm in fibrillar and punctuate patterns
(19) of decidual cells was shown. Interestingly, oncofetal
fibronectins having III-B or O-glycosylated III-V domains
have been detected only in decidua that has been invaded
by the trophoblast (18). The results of this study suggest
that the deposition of specific fibronectin isoforms in the
decidual matrix may result in a response to EVT cell
migration and invasion. Our recent study (20) indicated
that there is also a relationship between fibronectin
isoforms and pH environment for trophoblastic invasion.
We concluded the pH played an important role as a
regulator of human trophoblast differentiation.

Besides β chain lacking fibrinopeptide, a variety of
polypeptides having molecular masses over 105kD, have
been reported in Nitabuch’s fibrinoid (21). Among these
polypeptides, basement membrane proteins (collagen
type IV and laminin) have been shown to be present in
this region. In the present study, Western blots also
reveal the presence of different fibronectin isoforms;
general and cellular fibronectins are the most prominent
ones, while oncofetal isoforms and gelatin domain
containing isoforms are at very low amounts and almost
undetectable.
The synthesis of fibronectin by the venous and arterial
endothelia of the human umbilical cord has been
previously reported (22) but their types and molecular
events were not indicated. In this study, the results
obtained from Western blots show the presence of
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familiar and cellular fibronectin isoforms in umbilical cord
extracts. In addition, the oncofetal isoforms are not
detectable.
According to previous studies, in the term placenta,
the stroma of the chorionic villi (23,24) and surrounding
of the fetal vessels (25) have shown immunoreactivities
with fibronectin, while the trophoblastic basement
membrane has shown no immunoreactivity (26). In
parallel to these reports, this study shows that the stroma
of large stem villi (27) and the surroundings of fetal
vessels are composed of general and cellular fibronectin
isoforms, whereas the presence of these isoforms was
not detectable in the trophoblastic cover and in the other
types of villi. In addition, the villous stroma did not
consist of oncofetal fibronectin isoform that has an Oglycosylated domain in addition to the findings of
previous reports (oncofetal fibronectin that has III-B
domain) (28).
Finally, we conclude that fibronectin and its isoforms
are distributed in different human placental sites with
varying intensity due to features of the fetoplacental
membrane and decidual components. Fibronectin
isoforms are highly detectable immunoreactively in these
sites due to the presence of EVT, but in amnionic
components having no EVT cells the lack of any
immunoreaction of all fibronectin isoforms, except the

oncofetal isoform, indicates a high activity of the rapid
growth of the fetus and its closed membranes. In
conclusion, fibronectin isoforms play an important role in
trophoblastic invasion and placental development during
pregnancy.
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